Shire grabs FDA ok with blockbuster potential

The U.S. FDA has approved a first of its kind drug from Shire to treat patients suffering from a rare disease, hereditary angioedema (HAE).

Source: PharmaManufacturing.com - August 24, 2018 Category: Pharmaceuticals Source Type: news